RE-BVS – Piemonte Repository

Sfoglia per AUTORE
REMéNYI P
Collezione AOU Città della Salute di Torino

Items : 5

Prognostic factors impacting post-transplant outcomes in adult T-cell acute lymphoblastic leukemia: a registry-based study by the EBMT acute leukemia working party. in Bone marrow transplantation / Bone Marrow Transplant. 2024 Sep;59(9):1239-1246. doi: 10.1038/s41409-024-02300-8. Epub 2024 Jun 4.

2024
AOU Città della Salute di Torino

Peric Z; Giebel S; Stelljes M; Brissot E; Balsat M; Busca A; Burt R; Rambaldi A; Sakellari I; Schroeder T; Helbig G; Socie G; Castilla-Llorente C; Salmenniemi U; Ozcelik T; Wu D; Mousavi A; Aljurf M; Kulagin A; Reményi P; Galimard JE; Ngoya M; El Cheikh J; Nagler A; Bazarbachi A; Ciceri F; Mohty M;

Correction: Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT. in Journal of hematology & oncology / J Hematol Oncol. 2023 Sep 29;16(1):106. doi: 10.1186/s13045-023-01501-w.

2023
AOU Città della Salute di Torino

Nagler A; Labopin M; Blaise D; Raiola AM; Corral LL; Bramanti S; Sica S; Kwon M; Koc Y; Pavlu J; Kulagin A; Busca A; Rodríguez AB; Reményi P; Schmid C; Brissot E; Sanz J; Bazarbachi A; Giebel S; Ciceri F; Mohty M;

Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT. in Journal of hematology & oncology / J Hematol Oncol. 2023 May 29;16(1):58. doi: 10.1186/s13045-023-01450-4.

2023
AOU Città della Salute di Torino

Prediction of Nonrelapse Mortality in Patients With Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation With Posttransplantation Cyclophosphamide-based Graft Versus Host Disease Prophylaxis. in HemaSphere / Hemasphere. 2023 Feb 21;7(3):e846. doi: 10.1097/HS9.0000000000000846. eCollection 2023 Mar.

2023
AOU Città della Salute di Torino

Hermans SJF; Versluis J; Labopin M; Giebel S; van Norden Y; Moiseev I; Blaise D; Díez Martín JL; Meijer E; Rovira M; Choi G; Raiola AM; Koc Y; Reményi P; Vydra J; Kröger N; Sica S; Martino M; van Gorkom G; Chevallier P; Busca A; Herrera Arroyo C; Brissot E; Peric Z; Nagler A; Shouval R; Ciceri F; Cornelissen JJ; Mohty M; et alii...

Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies. in Frontiers in immunology / Front Immunol. 2021 Feb 2;11:613954. doi: 10.3389/fimmu.2020.613954. eCollection 2020.

2020
AOU Città della Salute di Torino

Schoemans H; Kroschinsky F; Yakoub-Agha I; Sengeloev H; Scheid C; Niederwieser D; Ladetto M; Afanasyev B; Corradini P; Kröger N; Castagna L; Rambaldi A; Socié G; Bruno B; Solano C; Chevallier P; Bourhis JH; Ciceri F; Reményi P; Milpied N; Kanfer E; van der Werf S; Blaise D; Beohou E; Jagasia M; Tomaszewska A; Koenecke C; Penack O; Peri? Z; et alii...